Medi-first Plus Antiseptic Wipes Cloth
FDA Recall NDC 47682-252

FDA Enforcement Report: View Recall Date, Reasons, and Safety Status

Active & Historical Enforcement Reports

The FDA has identified 1 recorded enforcement report(s) associated with Medi-first Plus Antiseptic Wipes (NDC 47682-252). A significant event, classified as Class II, was initiated on Jan 20, 2026 by Unifirst First Aid Corporation. The reported reason for this action was: "CGMP Deviations"

This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.

Reported Recall Events

January 2026 Class II Recall: CGMP Deviations

Recall Number
Class II Ongoing
Reason for Recall
CGMP Deviations
Initiated
Jan 20, 2026
Reported
Mar 11, 2026
Quantity
N/A

Recall Profile & Regulatory Data

Event ID
98291
Classification
Class II
Enforcement Status
Ongoing
Recalling Firm
ACME UNITED CORPORATION
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Nationwide within the United States
Product Description
Medi-First Antiseptic Wipes (BZK)(Benzalkonium Chloride 0.13%), 100 wipes per box, Manufactured for Medique Products, Fort Meyers, FL, 33967, NDC 47682-122-33.
Batch or Lot Expiration Information
Lot# : MN15922, Exp. Date Apr 2027; MN31022, Exp. Date Oct 2027; MN27223, Exp. Date 2028-Aug.
Affected Packages Involved in this Recall
47682-122-99Product
47682-122-71Product
47682-122-33Product
47682-252-99Product
47682-252-71Product

About FDA Recall Enforcement Reports

FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.

If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.